{"rows":[{"id":4190,"title":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251387655","pubmed_id":"42539824","openalex_id":"https://openalex.org/W7117646156","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539824","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":50,"title":"Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases","authors":"Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew","journal":"Metabolic Engineering","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.ymben.2026.102490","pubmed_id":"42288133","openalex_id":"https://openalex.org/W7164759173","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Genomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288133","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.ymben.2026.102490","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288133","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","doi":"10.1016/j.ymben.2026.102490","pmid":"42288133","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4169,"title":"Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies","authors":"Belle Buzzi","journal":"VCU Scholars Compass (Virginia Commonwealth University)","publication_date":"2026-08-21","publication_year":2026,"doi":"10.25772/0t5k-3r51","pubmed_id":null,"openalex_id":"https://openalex.org/W7127870091","source_url":"https://scholarscompass.vcu.edu/etd/8246","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.25772/0t5k-3r51","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://scholarscompass.vcu.edu/etd/8246","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.25772/0t5k-3r51","source_url":"https://scholarscompass.vcu.edu/etd/8246","doi":"10.25772/0t5k-3r51","pmid":"","publication_date":"2026-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5873,"title":"Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.","authors":"Jaeckel LF, Logvinski D, Kanana M, Müller F, Rohner N, Becker AM, Liechti ME, Sterzer P.","journal":"Neuroscience of consciousness","publication_date":"2026-08-20","publication_year":2026,"doi":"10.1093/nc/niag050","pubmed_id":"42626628","openalex_id":null,"source_url":"https://doi.org/10.1093/nc/niag050","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Healthy Volunteers","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-22 01:20:05","last_checked":"2026-08-23 01:20:16","bibtex":null,"source_record_id":"PMID:42626628","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1093/nc/niag050","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42626628","source_url":"https://doi.org/10.1093/nc/niag050","doi":"10.1093/nc/niag050","pmid":"42626628","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5719,"title":"Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants","authors":"Mason, N. L.; Haijen-Bongers, E. C.; Kuypers, K. P. C.; Frick, A.; Toennes, S. W.; Mallaroni, P.; Ramaekers, J. G.","journal":"bioRxiv","publication_date":"2026-08-19","publication_year":2026,"doi":"10.64898/2026.07.08.737179","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.07.08.737179","substance_tags":"psilocybin","topic_tags":"Pharmacology,Mechanism of Action,Healthy Volunteers,Safety","study_type":"Clinical Trial","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-07-14 01:27:23","last_checked":"2026-08-21 01:26:27","bibtex":null,"source_record_id":"DOI:10.64898/2026.07.08.737179","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.07.08.737179","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.07.08.737179","source_url":"https://doi.org/10.64898/2026.07.08.737179","doi":"10.64898/2026.07.08.737179","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":3515,"title":"Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes","authors":"Yale University","journal":"ClinicalTrials.gov","publication_date":"2026-08-19","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07306364","substance_tags":"psilocybin","topic_tags":"Addiction,Chronic Pain,Mechanism of Action,Animal Study","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07306364","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07306364","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07306364","source_url":"https://clinicaltrials.gov/study/NCT07306364","doi":"","pmid":"","publication_date":"2026-08-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5866,"title":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","authors":"Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements","journal":null,"publication_date":"2026-08-17","publication_year":2026,"doi":"10.5281/zenodo.21983116","pubmed_id":null,"openalex_id":"https://openalex.org/W7203633773","source_url":"https://doi.org/10.5281/zenodo.21983116","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-19 01:20:25","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21983116","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21983116","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21983116","source_url":"https://doi.org/10.5281/zenodo.21983116","doi":"10.5281/zenodo.21983116","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.","authors":"Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5742,"title":"An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life","authors":"Charles Raison","journal":"ClinicalTrials.gov","publication_date":"2026-08-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07719088","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-23 01:25:56","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07719088","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07719088","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07719088","source_url":"https://clinicaltrials.gov/study/NCT07719088","doi":"","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":3626,"title":"The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults","authors":"Region Skane","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07169747","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-21 01:27:47","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07169747","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07169747","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07169747","source_url":"https://clinicaltrials.gov/study/NCT07169747","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5863,"title":"Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy","authors":"Brian Ross","journal":"Journal of Psychedelic Studies","publication_date":"2026-08-13","publication_year":2026,"doi":"10.1556/2054.2026.00517","pubmed_id":null,"openalex_id":"https://openalex.org/W7202362192","source_url":"https://doi.org/10.1556/2054.2026.00517","substance_tags":"psilocybin","topic_tags":"Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Review Article,Animal Study,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-15 01:20:13","last_checked":"2026-08-20 01:20:19","bibtex":null,"source_record_id":"DOI:10.1556/2054.2026.00517","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1556/2054.2026.00517","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00517","source_url":"https://doi.org/10.1556/2054.2026.00517","doi":"10.1556/2054.2026.00517","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3440,"title":"Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial","authors":"Brigham and Women's Hospital","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07296094","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07296094","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07296094","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296094","source_url":"https://clinicaltrials.gov/study/NCT07296094","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":5860,"title":"Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task","authors":"Anderson, D.; Maillot, N.; Thomas, C. W.; Golden, C. T.; Gilmour, G.; Robinson, E. S.","journal":"bioRxiv","publication_date":"2026-08-12","publication_year":2026,"doi":"10.64898/2026.08.06.743309","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.06.743309","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Aging","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-08-13 01:24:42","last_checked":"2026-08-19 01:22:49","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.06.743309","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.06.743309","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.08.06.743309","source_url":"https://doi.org/10.64898/2026.08.06.743309","doi":"10.64898/2026.08.06.743309","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5857,"title":"Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety","authors":"Salgaço Mateus Kawata, Farias David de Paulo, Souza Mariela Zucolo de, Sartoratto Adilson, Bottino Flavia, Barud Hernane da Silva, Oliveira Fellipe Lopes de, Medeiros Alexandra Ivo de, Raimundo Breno Vilas Boas, Nascimento Victor Hugo, Galdino Taynah P., Silva Suédina M. L., Fook Marcus V. L., Sivieri Katia","journal":"Drugs and Drug Candidates","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/ddc5030046","pubmed_id":null,"openalex_id":"https://openalex.org/W7202271098","source_url":"https://doi.org/10.3390/ddc5030046","substance_tags":"psilocybin,psilocin","topic_tags":"Anxiety,Pharmacology,Mechanism of Action,Animal Study,In Vitro Study,Microbiome,Inflammation,Immune Function","study_type":"In Vitro Study","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"DOI:10.3390/ddc5030046","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/ddc5030046","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/ddc5030046","source_url":"https://doi.org/10.3390/ddc5030046","doi":"10.3390/ddc5030046","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5856,"title":"Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)","authors":"Anghel Teodora, Cojocaru Adriana, Hogea Lavinia, Costea Iuliana, Marinca Amalia, Dumache Raluca, Nussbaum Laura, Trăilă Iuliana-Anamaria","journal":"Journal of Clinical Medicine","publication_date":"2026-08-12","publication_year":2026,"doi":"10.3390/jcm15166228","pubmed_id":null,"openalex_id":"https://openalex.org/W7202254245","source_url":"https://doi.org/10.3390/jcm15166228","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-13 01:20:21","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"DOI:10.3390/jcm15166228","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3390/jcm15166228","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3390/jcm15166228","source_url":"https://doi.org/10.3390/jcm15166228","doi":"10.3390/jcm15166228","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3587,"title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder","authors":"NYU Langone Health","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06349083","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06349083","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06349083","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06349083","source_url":"https://clinicaltrials.gov/study/NCT06349083","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3574,"title":"Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids","authors":"Roswell Park Cancer Institute","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06827054","substance_tags":"psilocybin","topic_tags":"Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06827054","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06827054","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06827054","source_url":"https://clinicaltrials.gov/study/NCT06827054","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5855,"title":"Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.","authors":"Kaadt E, Søkilde RF, Garling HD, Raval NR, Lundgaard L, Just J, Knudsen GM, Elfving B.","journal":"European journal of pharmacology","publication_date":"2026-08-11","publication_year":2026,"doi":"10.1016/j.ejphar.2026.179222","pubmed_id":"42580506","openalex_id":null,"source_url":"https://doi.org/10.1016/j.ejphar.2026.179222","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Adolescents","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-13 01:20:05","last_checked":"2026-08-18 01:20:10","bibtex":null,"source_record_id":"PMID:42580506","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.ejphar.2026.179222","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42580506","source_url":"https://doi.org/10.1016/j.ejphar.2026.179222","doi":"10.1016/j.ejphar.2026.179222","pmid":"42580506","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5854,"title":"Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.","authors":"Todesco S, Allan Z, Liu MYM, Schütz C.","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2026-08-11","publication_year":2026,"doi":"10.1016/j.pnpbp.2026.111888","pubmed_id":"42580581","openalex_id":null,"source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-13 01:20:05","last_checked":"2026-08-18 01:20:11","bibtex":null,"source_record_id":"PMID:42580581","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42580581","source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","doi":"10.1016/j.pnpbp.2026.111888","pmid":"42580581","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5853,"title":"Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.","authors":"Ke X, Du X, Wang X.","journal":"Molecular psychiatry","publication_date":"2026-08-11","publication_year":2026,"doi":"10.1038/s41380-026-03816-9","pubmed_id":"42581074","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03816-9","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Drug Interactions,Immune Function","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-13 01:20:05","last_checked":"2026-08-18 01:20:10","bibtex":null,"source_record_id":"PMID:42581074","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03816-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42581074","source_url":"https://doi.org/10.1038/s41380-026-03816-9","doi":"10.1038/s41380-026-03816-9","pmid":"42581074","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}}],"total":1073,"page":1,"per_page":20,"pages":54,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Mechanism of Action","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}